Vitamin B12 deficiency, including pernicious anaemia: diagnosis and management
In development [GID-NG10176] Expected publication date: 01 November 2023
Search results
602 results
-
-
Burosumab for treating FGF23-related hypophosphataemia in tumour-induced osteomalacia [ID3924 ]
In development [GID-TA10822] Expected publication date: TBC
-
Transcutaneous electrical stimulation of the trigeminal nerve for ADHD
In development [GID-IPG10210] Expected publication date: TBC
-
Percutaneous image-guided cryoablation of peripheral neuroma for chronic pain
In development [GID-IPG10208] Expected publication date: TBC
-
Focal resurfacing implants to treat articular cartilage damage in the knee
In development [GID-IPG10202] Expected publication date: 17 August 2022
-
Superficial venous arterialisation and selective venous occlusion for chronic limb threatening ischaemia in people with no other option for revascularisation
In development [GID-IPG10192] Expected publication date: 17 August 2022
-
Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies [ID3950]
In development [GID-TA10849] Expected publication date: 19 July 2023
-
Pembrolizumab with lenvatinib for previously treated advanced, metastatic or recurrent endometrial cancer [ID3811]
In development [GID-TA10692] Expected publication date: 04 January 2023
-
Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer (Review of TA619) [ID3779]
In development [GID-TA10901] Expected publication date: 23 November 2022
-
Lu vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after 2 or more therapies [ID3840]
In development [GID-TA10730] Expected publication date: 23 November 2022
-
Eflornithine for maintenance treatment of high-risk neuroblastoma after 1 therapy in people up to 21 years [ID4060]
In development [GID-TA10990] Expected publication date: TBC
-
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis
In development [GID-IPG10194] Expected publication date: 23 November 2022
-
Trabeculectomy with biodegradable collagen matrix implant for glaucoma
In development [GID-IPG10211] Expected publication date: 10 January 2023
-
MRI fusion biopsy in people with suspected prostate cancer
In development [GID-DG10050] Expected publication date: 17 May 2023
-
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3907 ]
In development [GID-TA10784] Expected publication date: TBC
-
Nivolumab with chemotherapy for neoadjuvant treatment of early non-small-cell lung cancer [ID3757]
In development [GID-TA10632] Expected publication date: TBC
-
Removal, preservation and subsequent re-implantation of ovarian tissue to prevent symptoms from the menopause
In development [GID-IPG10170] Expected publication date: 21 September 2022
-
Vadadustat for treating anaemia in people with chronic kidney disease [ID3821]
In development [GID-TA10877] Expected publication date: TBC
-
Rimegepant for treating or preventing migraine [ID1539]
In development [GID-TA10839] Expected publication date: 01 March 2023
-
Diabetic foot problems: prevention and management (update)
In development [GID-NG10285] Expected publication date: 18 January 2023
-
PLGF-based testing to help diagnose suspected preterm pre-eclampsia (update of DG23)
In development [GID-DG10040] Expected publication date: 27 July 2022
-
Artificial intelligence (AI) software to help clinical decision making in stroke
In development [GID-DG10044] Expected publication date: 27 July 2022
-
GID-MT564 GreenLight XPS for treating benign prostatic hyperplasia
In development [GID-MT564] Expected publication date: 14 October 2022
-
GID-MT565 Optilume for recurrent bulbar urethral strictures
In development [GID-MT565] Expected publication date: 28 November 2022
-
Mosunetuzumab for treating relapsed or refractory follicular lymphoma [ID3931]
In development [GID-TA10816] Expected publication date: 25 January 2023
-
Oleogel-S10 for treating skin wounds associated with epidermolysis bullosa ID1505
In development [GID-TA10654] Expected publication date: TBC
-
Software with artificial intelligence derived algorithms for automated detection and analysis of lung nodules from CT scan images
In development [GID-DG10046] Expected publication date: 28 June 2023
-
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency [ID3791]
In development [GID-HST10052] Expected publication date: 29 March 2023
-
Targeted-release budesonide for treating IgA nephropathy ID1434
In development [GID-TA11028] Expected publication date: TBC
-
Type 2 diabetes in adults: management (medicines update)
In development [GID-NG10336] Expected publication date: TBC
-
Pembrolizumab with platinum-based chemotherapy and radiation for treating unresectable locally advanced squamous cell carcinoma of the head and neck [ID1667]
In development [GID-TA10567] Expected publication date: 18 October 2023
-
Pembrolizumab for adjuvant treatment of resected stage 2 melanoma with high risk of recurrence [ID3908 ]
In development [GID-TA10786] Expected publication date: TBC
-
Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox [ID350]
In development [GID-TAG423] Expected publication date: TBC
-
Nivolumab in combination for untreated advanced unresectable recurrent or metastatic oesophageal squamous cell carcinoma [ID2712]
In development [GID-TA10572] Expected publication date: 23 November 2022
-
Apalutamide for treating non-metastatic, hormone-relapsed prostate cancer [ID1174]
In development [GID-TA10377] Expected publication date: TBC
-
Voclosporin with immunosuppressives for treating lupus nephritis [ID3962]
In development [GID-TA10878] Expected publication date: 25 January 2023
-
Autologous auto-CD19-transduced CD3+ cells for treating relapsed or refractory B-precursor acute lymphoblastic leukaemia in adults ID1494
In development [GID-TA10424] Expected publication date: 14 December 2022
-
Head injury: assessment and early management
In development [GID-NG10164] Expected publication date: 23 February 2023
-
Memokath-051 stent for ureteric obstruction
In development [GID-MT569] Expected publication date: 07 December 2022
-
Lower urinary tract symptoms in men: management
In development [GID-NG10300] Expected publication date: TBC
-
Neratinib for treating HER2-positive breast cancer after 2 therapies [ID1381]
In development [GID-TA10539] Expected publication date: TBC
-
Sebelipase alfa for treating Wolman disease [ID3995]
In development [GID-HST10047] Expected publication date: TBC
-
Capmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping [ID1387]
In development [GID-TA10846] Expected publication date: TBC
-
Nivolumab-relatlimab for untreated advanced or metastatic melanoma [ID1688]
In development [GID-TA10581] Expected publication date: TBC
-
Dapagliflozin for treating heart failure with preserved ejection fraction ID1648
In development [GID-TA10942] Expected publication date: TBC
-
Ranibizumab port delivery system for treating wet age-related macular degeneration [ID3983]
In development [GID-TA10879] Expected publication date: TBC
-
Obesity - phentermine (with topiramate) [ID543]
In development [GID-TAG439] Expected publication date: TBC
-
Pembrolizumab for previously treated oesophageal or gastro-oesophageal junction cancer ID1357
In development [GID-TA10322] Expected publication date: TBC
-
ERC1671 for treating progressed or recurrent grade IV glioma (glioblastoma or gliosarcoma) [ID1623]
In development [GID-TA10489] Expected publication date: TBC
-
Lymphoma (non Hodgkin's, peripheral T-cell) - pralatrexate [ID368]
In development [GID-TAG424] Expected publication date: TBC